2014 ACTHIV Posters

Intelence and Prezista Once a Day Study (INROADS): A Multicenter, Single-Arm, Open-Label Study of Once Daily Combination of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) As Dual Therapy in Early Treatment- Experienced and Treatment-Naïve With Transmitted Resistance Subjects

  • Peter Ruane, MD, Peter J. Ruane MD, Inc.
  • Cynthia Brinson, MD, Central Texas Clinical Research
  • Princy Kumar, MD, Georgetown University School of Medicine
  • Edwin DeJesus, MD, Orlando Immunology Center
  • Adam Shprecher, PharmD, Janssen Scientific Affairs, LLC
  • Robert Ryan, MS, Janssen Research and Development
  • Michelle Cho, PharmD, Janssen Scientific Affairs, LLC
  • David Anderson, MD,Janssen Scientific Affairs, LLC

 

Integration of Psychology Services in HIV Primary Care Increases Access to Mental Health Treatment 

  • Leah E. Squires, PhD, Washington DC VAMC
  • Kathryn Schaefer Ziemer, M.A., Washington DC VAMC
  • Tracela White, PhD, Washington DC VAMC
  • Melissa Turner, MSW, LICSW, Washington DC VAMC
  • Linda Allen, MSW, LICSW, Washington DC VAMC
  • Debra Benator, PhD, FACP, FIDSA, Washington DC VAMC

 

Comparing Adherence to Medications Used in Treating Comorbid Conditions Among Older HIV Patients Using HIV-Specialized Pharmacies and Traditional Pharmacies

  • Janeen DuChane, PhD, Walgreen Co.
  • Glen Pietrandoni, RPh, AAHIVP
  • Julia Zhu, MPH, MS, Walgreens

 

Affordable Care Act (ACA) and Impact on HIV – A Review of Literature 

  • North Shore LIJ Hospital, NY

 

Self-Reported Reasons Why HIV/AIDS Patients Miss Appointments in a Metropolitan Specialty Clinic 

  • Sam Wijesinghe, MS, MPAS, UCSF, Fresno Family and Community Medicine
  • Ivan Gomez, MD, UCSF, Fresno Family and Community Medicine
  • Alex Moir, MD, UCSF, Fresno Family and Community Medicine
  • Susan Hughes, MS, UCSF, Fresno Family and Community Medicine
  • Roger Mortimer, MD, UCSF, Fresno Family and Community Medicine
  • Simon Paul, MD, UCSF, Fresno Internal Medicine